Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin
about
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin
description
scientific article published on 28 November 2019
@en
name
Insulin degludec/liraglutide ( ...... uncontrolled on basal insulin
@en
type
label
Insulin degludec/liraglutide ( ...... uncontrolled on basal insulin
@en
prefLabel
Insulin degludec/liraglutide ( ...... uncontrolled on basal insulin
@en
P2093
P356
P1433
P1476
Insulin degludec/liraglutide ( ...... uncontrolled on basal insulin
@en
P2093
M F Ranthe
T Vilsbøll
P304
P356
10.1111/DME.14178
P577
2019-11-28T00:00:00Z